Skip to main content
. Author manuscript; available in PMC: 2022 Apr 9.
Published in final edited form as: ACS Infect Dis. 2021 Mar 16;7(4):826–837. doi: 10.1021/acsinfecdis.0c00682

Table 3.

Steady-State Kinetic Parameters with Purified PenA1 and R220A β-Lactamases

Ki-app (μM) PenA1 R220A fold increase
avibactam 0.5 ± 0.1 13 ± 3 26
relebactam 9 ± 1 110 ± 17 12
clavulanic acid 5 ± 1 26 ± 3 5
tazobactam 0.6 ± 0.1 36 ± 10 60
enmetazobactam 1.1 ± 0.3 24 ± 5 22
vaborbactam 38 ± 4 108 ± 10 3
k2/K (M−1 s−1) PenA1 R220A fold decrease
avibactam 2 ± 1 × 106 5.2 ± 0.1 × 103 385
relebactam 1.1 ± 0.2 × 104 2.3 ± 0.8 × 102 48
clavulanic acid 6.3 ± 0.1 × 103 3.4 ± 0.2 × 103 1.9
tazobactam 1.3 ± 1.0 × 105 3.2 ± 0.4 × 103 41
enmetazobactam 6.3 ± 2.0 × 105 8.1 ± 1.5 × 103 77
vaborbactam 3.4 ± 0.1 × 102 8.4 ± 2.0 × 101 4
tn (15 min) PenA1 R220A fold decrease
avibactam 5 10 2b
relebactam 10 50 5b
clavulanic acid 5000 2000 2.5
tazobactam 50 10 5
enmetazobactam 100 10 10
vaborbactam 200a 100a 2
a

Represents the stoichiometry of inactivation, as vaborbactam does not undergo side reactions or hydrolysis.

b

The represented fold change values are increased not decreased for the DBOs.